Oxidative stress, AGE, and atherosclerosis

Slides:



Advertisements
Similar presentations
03/06/231 K June /06/232 Atherosclerosis Etiology Classic Risk Factors Dyslipidemia Low HDL Epidemiological Studies (e.g. Framingham) Genetic.
Advertisements

Volume 29, Issue 1, Pages 1-7 (January 2013)
Oxidants and antioxidants in alcohol-induced liver disease
Bart Staels, PhD  The American Journal of Medicine 
Volume 17, Issue 6, Pages (June 2013)
by William C. Aird Blood Volume 101(10): May 15, 2003
Oxidants and antioxidants in alcohol-induced liver disease
Dylan Burger, Adeera Levin  Kidney International 
Metabolic stress-induced joint inflammation and osteoarthritis
Ding Ai, John Y.-J. Shyy, Yi Zhu  Kidney International 
The marriage of glucose and blood vessels: It isn’t all that sweet
Vascular dysfunction in diabetes mellitus
Molecular mechanisms of diabetic renal hypertrophy
Inflammation and wasting in chronic kidney disease: Partners in crime
AMPK Keeps Tumor Cells from Starving to Death
Complementing T Cells’ Functions: Bringing in Metabolism Matters
Life Is Short, if Sweet Cell Metabolism
Endothelial cell dysfunction and nitric oxide synthase
Volume 58, Issue 1, Pages (July 2000)
Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway  Tetsuya Kubota, Naoto Kubota, Takashi Kadowaki 
Volume 85, Issue 3, Pages (March 2014)
Diabetes and atherosclerosis
The aging ovary—the poor granulosa cells
Hsueh Yang, Gabrielle Curinga, Cecilia M. Giachelli 
Volume 86, Issue 4, Pages (October 2014)
Volume 70, Issue 7, Pages (October 2006)
Volume 64, Issue 5, Pages (November 2003)
Volume 65, Issue 5, Pages (May 2004)
Volume 70, Issue 11, Pages (December 2006)
Volume 73, Issue 4, Pages (February 2008)
Volume 76, Issue 11, Pages (December 2009)
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Live Longer sans the AT1A Receptor
Reducing lipids for CV protection in CKD patients—current evidence
The epidemiology of chronic kidney disease
Hypoxia-Inducible Factors in Physiology and Medicine
The role of protein kinase C activation in diabetic nephropathy
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?  Mustafa Arici, John Walls  Kidney International 
Volume 70, Issue 10, Pages (November 2006)
Banking on ATM as a new target in metabolic syndrome
F. Verrey, P. Fakitsas, G. Adam, O. Staub  Kidney International 
p38δ and PKD1: Kinase Switches for Insulin Secretion
Volume 72, Issue 8, Pages (October 2007)
Macrophages and hypoxia in human chronic kidney disease
Volume 83, Issue 4, Pages (April 2013)
Endothelial dysfunction and inflammation: What is the link?
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Tobias R. Kollmann, Ofer Levy, Ruth R. Montgomery, Stanislas Goriely 
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Kidney failure and the gut: p-cresol and the dangers from within
Acute renal failure: From renal physiology to the renal transcriptome
Kathryn E. Wellen, Craig B. Thompson  Molecular Cell 
Volume 58, Issue 2, Pages (August 2000)
Inflammation and hypoxia in the kidney: friends or foes?
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Organ transplantation goes to the movies
Nanocrystals seed calcification in more ways than one
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?  Mustafa Arici, John Walls  Kidney International 
Volume 69, Issue 5, Pages (March 2006)
Renin–angiotensin system blockade and diabetes: moving the adipose organ from the periphery to the center  Oliver Lenz, Alessia Fornoni  Kidney International 
Volume 76, Issue 5, Pages (September 2009)
Volume 70, Issue 3, Pages (August 2006)
Kathryn E. Wellen, Craig B. Thompson  Molecular Cell 
Volume 71, Issue 9, Pages (May 2007)
Calorie Restriction— the SIR2 Connection
Pathophysiologic pathways of hematuria-induced kidney damage.
High glucose and renin release: the role of succinate and GPR91
Christian Rask-Madsen, George L. King  Cell Metabolism 
Presentation transcript:

Oxidative stress, AGE, and atherosclerosis E. Schleicher, U. Friess  Kidney International  Volume 72, Pages S17-S26 (August 2007) DOI: 10.1038/sj.ki.5002382 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Working hypothesis for the accelerated atherosclerosis in diabetes. Reactive ROS and AGEs that react via the RAGE are generated if the vascular wall is stressed. Because all three partners are linked a vicious cycle is induced. This cycle is enhanced by further stress factors occurring in diabetes. Kidney International 2007 72, S17-S26DOI: (10.1038/sj.ki.5002382) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Vascular cells are protected from excessive glucose uptake. Vascular cells express GLUTs with Km between 2 and 5 mM (e.g. GLUT 1 and GLUT 4), whereas the Km of GLUT 2, which is expressed in liver and the pancreatic β-cell, is 22 mM. The graphs show the dependency of the relative glucose transport rate from glucose concentration. Vertical lines indicate glucose concentrations of 4, 7.5, and 15 mM (80, 135, and 270 mg/dl), respectively, to indicate the ranges of daily variations of blood glucose levels in nondiabetic and diabetic subjects. Kidney International 2007 72, S17-S26DOI: (10.1038/sj.ki.5002382) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 Effects of ROS in vascular cells. Numerous inducers and metabolic conditions associated with atherogenesis add up to increase intracellular ROS from enzymatic and mitochondrial sources. Once enhanced ROS formation is started, subsequent activation of signaling pathways and the redox-sensitive transcription factors NF-κB and AP-1 has been shown to modulate the expression of proinflammatory cytokines and other genes relevant to vascular pathology such as RAGE, VCAM, or monocyte chemoattractant protein-1. Upregulated cytokine expression and accumulating AGEs may, in turn, provide potent feedback loops to sustain cellular oxidative stress and proinflammatory response. Kidney International 2007 72, S17-S26DOI: (10.1038/sj.ki.5002382) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 4 The physiological vascular stress induced by hemodynamic and metabolic factors can readily be counteracted by low-grade production of ROS and/or cytokines. However, when sustained stress induced by cytokine generation in ectopic fat, or by hypertension, hyperglycemia, etc. chronically challenges the vascular wall a vicious cycle is induced consisting of elevated and sustained activation of ROS, RAGE/NF-κB activation, and cytokines. Subsequent changes in the vascular wall, for example endothelial dysfunction and intima media thickening (IMT) indicate early changes possibly leading to atherosclerosis. Kidney International 2007 72, S17-S26DOI: (10.1038/sj.ki.5002382) Copyright © 2007 International Society of Nephrology Terms and Conditions